RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Hepatitis

A collection of news and information related to Hepatitis published by this site and its partners.

Top Hepatitis Articles

Displaying items 1-12
  • The $84,000 hepatitis drug [Letter]

    It was interesting to read that there is now a cure for hepatitis C in the form of new drugs that are capable of completely suppressing the virus in 90 percent of patients in 8 to 12 weeks ("Gilead Sciences' $84,000 price for hepatitis drug is...
  • Achillion's hepatitis C drug shows promise in trial

    (Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. The mid-stage trial tested Achillion's...
  • UK cost body backs pricey Gilead hepatitis pill for some patients

    LONDON (Reuters) - Gilead Sciences' expensive new hepatitis C pill has been endorsed for use in certain patients by Britain's healthcare cost-effectiveness watchdog, after the U.S. firm provided more information. The National Institute for Health and...
  • Vertex to end sales of hepatitis C drug Incivek

    (Reuters) - Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc. On Monday, Vertex sent a letter to doctors who...
  • Another Obamacare goal: Spend money on prevention, save money on cure

    Another Obamacare goal: Spend money on prevention, save money on cure
    Randy Gutzke, a longtime IV drug user who says he struggles daily to stay sober, recently was offered a quick-results test for hepatitis C at a West Side community health center. A case manager also reviewed the behaviors that put him at risk for...
  • U.S. senators ask Gilead Sciences to explain high cost of hepatitis C drug

    Two U.S. senators asked Gilead Sciences Inc. to produce documents explaining why its new hepatitis C drug is priced at $84,000 per treatment course, raising renewed concerns over the high costs to taxpayers. In a letter sent Friday, Ron Wyden (D-Ore.)...
  • 'True Blood' recap: Bon Temps celebrates life as body count grows

    'True Blood' recap: Bon Temps celebrates life as body count grows
    It’s hard to imagine a more challenging time in Bon Temps as the town struggles to recover from vampire attacks, vigilantism and the deadly hepatitis V virus. Exhausted Sookie Stackhouse (Anna Paquin) wants to mourn the dead alone, but her friends...
  • New drugs offer easier, more effective Hepatitis C treatment

    Harvard Health Blog If you're a baby boomer, the U.S. Centers for Disease Control and Prevention (CDC) recommends that you be tested for infection with the hepatitis C virus. The virus can live in the liver for decades, often causing silent damage that...
  • AbbVie says hepatitis C regimen gets nod for FDA priority review

    AbbVie says hepatitis C regimen gets nod for FDA priority review
    U.S. regulators have granted priority review for AbbVie Inc's experimental all-oral regimen for patients infected with the most common genotype of hepatitis C virus, the company said on Friday. The priority review means the Food and Drug...
  • Despite ridicule, Egypt pushes ahead with AIDS, hepatitis 'cure'

    Egypt’s military on Saturday pressed ahead with promotion of a fanciful device it claims can diagnose and cure AIDS and hepatitis, announcing that it would be tested in the next six months on larger numbers of patients in army hospitals. It was...
  • CDC: Vaccines given over 20 years prevented 731,700 premature deaths

    CDC: Vaccines given over 20 years prevented 731,700 premature deaths
    How much are childhood vaccines worth to America? Nearly $1.7 trillion, according to the Centers for Disease Control and Prevention. That dollar figure represents the net savings of 20 years’ worth of vaccines administered to American children...
  • AbbVie profit jumps 7% on strong Humira sales

    AbbVie profit jumps 7% on strong Humira sales
    AbbVie Inc. posted better-than-expected first-quarter earnings on Friday, propelled by another strong quarter of sales of the blockbuster drug Humira. The North Chicago-based pharmaceutical company said Friday that revenue rose 5.4 percent to $4.56...